---
title: "BGM Group names Zhanchang Xin chairman after Chen Xin resigns"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294416013.md"
description: "BGM Group announced that Chen Xin resigned as Chairman and Co-CEO on July 30, 2026. His father, Zhanchang Xin, was appointed Chairman effective the same date, bringing over 35 years of pharmaceutical R&D experience. Additionally, Hong Li was named Co-CEO, leveraging her background as CFO since 2008."
datetime: "2026-07-30T21:04:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294416013.md)
  - [en](https://longbridge.com/en/news/294416013.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294416013.md)
generator: "portal-rs"
---

# BGM Group names Zhanchang Xin chairman after Chen Xin resigns

-   Chairman and Co-CEO Chen Xin resigned effective July 30, 2026 for personal reasons. \* Zhanchang Xin named chairman effective July 30, 2026; has led Gansu Qilianshan Pharmaceutical since 2006 with 35+ years in pharma R&D. \* Hong Li appointed co-CEO effective July 30, 2026; CFO of Gansu Qilianshan Pharmaceutical since 2008 with a finance and accounting background. \* Zhanchang Xin is Chen Xin’s father. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BGM Group Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-088690), on July 30, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [BGM.US](https://longbridge.com/en/quote/BGM.US.md)

## Related News & Research

- [BGM Group menggelar RUPSLB untuk meminta persetujuan konsolidasi saham 30 banding 1](https://longbridge.com/en/news/295575806.md)
- [Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Reports Lower Q2 Expenses, Advances Lucid-MS Into Phase 2](https://longbridge.com/en/news/296129489.md)
- [Scisparc posts audited 2025 net loss of USD 12.56 million](https://longbridge.com/en/news/296357022.md)
- [Aardvark Therapeutics held annual shareholder meeting](https://longbridge.com/en/news/296141463.md)
- [CannaPharmaRx delays quarterly 10-Q filing for period ended June 30, 2026](https://longbridge.com/en/news/296135061.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**